Example: tourism industry

An Introduction to Clinical Trials: Type of Studies Design ...

An Introduction to Clinical Trials: Design IssuesEdgar R Miller III PhD, MDWelch Center for Prevention, Epidemiology and Clinical ResearchJohns Hopkins UniversitySchool of Medicine and Bloomberg School of Public Health2 Type of Studies Non-experimental (Observational) Case report Case series Cross-sectional (survey) Case-control Prospective, observational (cohort) Experimental Randomized, Clinical trial (RCT) 3 Study designs Observational Studies : Observeboth exposures and outcomes Experimental Studies ( Clinical trials) Assignexposures Observeoutcomes4 Advantages of Clinical Trials Often provides the strongest evidence in support of cause-effect relationships Basis for Clinical and public health policy Minimize/eliminate bias and confounding5 Randomized Clinical Tr

Jul 07, 2013 · An Introduction to Clinical Trials: Design Issues Edgar R Miller III PhD, MD Welch Center for Prevention, Epidemiology and Clinical Research Johns Hopkins University School of Medicine and Bloomberg School of Public Health 2 Type of Studies • Non-experimental (Observational) – Case report – Case series – Cross-sectional (survey ...

Tags:

  Research, Clinical, Clinical research

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of An Introduction to Clinical Trials: Type of Studies Design ...

1 An Introduction to Clinical Trials: Design IssuesEdgar R Miller III PhD, MDWelch Center for Prevention, Epidemiology and Clinical ResearchJohns Hopkins UniversitySchool of Medicine and Bloomberg School of Public Health2 Type of Studies Non-experimental (Observational) Case report Case series Cross-sectional (survey) Case-control Prospective, observational (cohort) Experimental Randomized, Clinical trial (RCT) 3 Study designs Observational Studies : Observeboth exposures and outcomes Experimental Studies ( Clinical trials)

2 Assignexposures Observeoutcomes4 Advantages of Clinical Trials Often provides the strongest evidence in support of cause-effect relationships Basis for Clinical and public health policy Minimize/eliminate bias and confounding5 Randomized Clinical TrialTarget PopulationStudy PopulationRANDOMIZEDS tandard TreatmentNew TreatmentDiseaseDisease6 Comparison of Study Designs Type of Study Design Dimension Cross-Sectional Case-Control Cohort RCTE stimate Prevalence A - B - Estimate Incidence - - A B Prove Causality C B- B+ A Generalizability A B+ B+ B Feasability A A B C 7 Core Elements of a Clinical Trial research Question Hypotheses Core Design Study Participants Recruitment Allocation Masking (Blinding)

3 Treatment Groups Data Analytical Issues Interpretation of Results8 The research Question Critical in the Design of a trial Types of questions: Assessing efficacy of an intervention Assessing the effectiveness of an intervention9 Types of Hypotheses Comparative Trial ( Superiority Trial) Objective: to demonstrate that a new therapy (n) is superior to standard therapy (s) in terms of incident outcome (I)HO: In= IsHA: In< Is (one tailed) or HA: In Is (two tailed) at some minimally detectable judged to have Clinical significance10 Types of Hypotheses Equivalence (non-inferiority trial) Objective: to demonstrate that a new therapy (n) is no worse than standard therapy (s) in terms of incident outcome (I) HO: In> IsHA.

4 In= Is at some , the maximum tolerable difference considered to be clinically acceptable11 Basic Types of DesignParallelCross-OverA A A BBBP arallel Study Design (PREMIER)ADVICE ONLYESTEST + DASHR andomizationPrimary Outcomes (6 months)End of Intervention (18 months)= Data Visit-12-10-8-6-4-2024 Baseline1234567 and 8 Control Diet Fruits-and-vegetables Diet DASHI ntervention Week**Conlin et al., Am J Hypertens, 2002 Cross-Over Study Design (OmniHeart)Period 16 weeksPeriod 26 weeksPeriod 36 weeksRandomization to 1 of 6 sequencesWashout Period2 4 wkWashout Period2-4 wkData:Run-In6 daysParticipants Ate Study FoodScreening/BaselineParticipants Ate Their Own FoodBlood Pressure Results (mmHg)Mean Change from Baseline in Each DietSystolic Only et al.

5 200516 Usual DietUsual DietRandomization to DietRun-in (11-14 days)Intervention (three 30-d periods in random order)Intermediate SodiumLower SodiumHigher SodiumLower SodiumIntermediate SodiumHigher SodiumDASH DietMixed Study Design (DASH-Sodium)Randomized SequenceEffect of Increased Sodium Intake on Systolic Blood Pressure in Two Diets: Results of the DASH-Sodium Trial*120125130135 SystolicBlood PressureAmerican DietDASH Diet65 100 140 Approximate Daily Sodium Intake (mmol/day) + + + + + <.0001+ <.

6 0001*Sacks et al, 200118 Factorial Design Type of trial in which individuals are randomized to two or more therapies (example: Physician s Health Study: tested aspirin (ASA) and -caroteneNeither -carotene onlyASA onlyBothNo -carotene -carotene No ASAASA10,00010,00010,000 10,000 20,000 The African American Study of Kidney Disease and Hypertension (AASK)AASK research QuestionsAmong African-Americans with early evidence of hypertension-related kidney disease: Does aggressive blood pressure control to a target blood pressure below current recommendations retard the progression of kidney disease?)

7 Do specific classes of anti-hypertensive medications retard the progression of kidney disease? Design of AASK Randomized, active controlled trial with a 2 x 3 factorial Design Participants: 1,094 African-Americans with hypertension-related renal insufficiency Planned follow-up of to 5 years Treatment Assignments (2:2:1 ratio of drug assignment)3 X 2 Factorial DesignN 441 436 217 MAP = Mean Arterial Pressure; * = referent group Metoprolol* Ramipril Amlodipine MAP <92 20% 20% 10% MAP 102-107 20% 20% 10% 23 Mean Arterial Pressure During Follow-upLower BP Goal (Achieved: 128/78)Usual BP Goal (Achieved: 141/85)MAP (mm Hg)8090100110120130 Follow-up Month0 41220283644526024RR=Risk Reduction, adjusted for baseline covariates% with EventsComposite Clinical OutcomeDeclining GFR Event, ESRD or DeathLow vs.

8 Usual:RR=2%, (p= )Lower BP (Achieved: 128/78)Usual BP (Achieved: 141/85)0510152025303540 Follow-Up Time (Months)0612182430364248546025 Main Clinical Composite OutcomeDeclining GFR Event, ESRD, or Death%with EventsMetoprolol vs. Amlodipine:RR= 20%, p= Ramipril vs. Amlodipine: RR= 38%, p= MetoprololRamiprilAmlodipine051015202530 3540 Follow-up Month06121824303642485460RR = Risk ReductionRamipril vs. MetoprololRR = 22%, p = = Risk Reduction, Adjusting for Baseline Covariates27 Study ParticipantsTarget PopulationAccessible PopulationStudy Samples28 Study Participants.

9 Example Target Population -> Healthy Elderly Accessible Population -> Retired Teachers Study Sample -> Volunteer Teachers who respond to mass mailing29 Study Participants Ideal Accessible Population high risk for disease candidates for treatment representative of target population feasibility considerations recruitment follow-up high quality data30 Enrollment Criteria Inclusion Criteria characteristics of accessible population Exclusion Criteria considerations related to: adherence to therapy follow-up safety ethics31 Common Recruitment Strategies General mailings Licensed drivers Voters Employee paychecks Targeted mailings HMO enrollees AARP members Mass media Radio TV ads Newspapers Posters/flyers Screenings Worksite Community Physician Referral Medical Record Review Internet / WWW Clinical trial registries Banner ads Social networks32 Comments on Recruitment Recruitment begins with Design Response rate is always lower than expected

10 Required resources are more than expected Dedicated personnel are necessary33 More Comments on Recruitment Recruitment period is often longer than expected Implement several strategies to identify best source Prepare back-up strategies Monitor recruitment Early Often Locally34 Recruitment Funnel (Example: VITAL Pilot Study)4,774 Mailed Invitations2,034 Questionnaires Returned765 Interested After Initial Mailing323 Randomizable after Second Mailing (7% cumulative)297 Randomized43%38%41%35 Allocation Random stratified blocked Non-Random haphazard systematic36 Why randomize?


Related search queries